VIEMED HEALTHCARE, INC.
Datakwaliteit: 100%
VMD
NASDAQ
Services
Health Services
€ 9,71
▲
€ 0,02
(0,21%)
6 months return
—
Momentum
Neutral
5Y revenue growth
23,27%
Groei
Revenue Growth (5Y)
23,27%
Boven sectorgemiddelde (3,76%)
Revenue (1Y)20,52%
Earnings (1Y)32,57%
FCF Growth (3Y)-21,00%
Kwaliteit
Return on Equity
10,93%
Boven sectorgemiddelde (-16,21%)
ROIC10,61%
Net Margin5,53%
Op. Margin8,49%
Veiligheid
Debt / Equity
0,15
Onder sectorgemiddelde (0,39)
Current Ratio1,13
Interest CoverageN/A
Waardering
PE (TTM|NTM|2027)
24,87 | 15,34 | 15,52
Boven sectorgemiddelde (-1,17)
P/B Ratio2,78
EV/EBITDA7,37
Dividend YieldN/A
Quick Summary
Key Takeaways
Short bullets derived from reported financials—not the AI summary above.
Revenue grew 23,27% annually over 5 years — strong growth
Earnings grew 32,57% over the past year
ROE of 10,93% — decent returns on equity
Debt/Equity of 0,15 — conservative balance sheet
Generating 11,93 M in free cash flow
Price History
Financiële Trends
Koersdoel Analisten
2 analisten
Hold
+33.9%
upside to target
Huidig
€ 9,71
Consensus Target
€ 13,00
€ 11,00
Laag
€ 15,00
Hoog
Vooruitzicht
Forward K/W
15,34
Forward WPA
€ 0,62
WPA Groei (sch.)
+29,2%
Omzet Sch.
362,70 M
Winstverassingen
EPS
Reported
Estimate
Forecast
Next: Q1 2026
·
EPS Est: € 0,09
·
Rev Est: 74,40 M
| Q12025 | Q22025 | Q32025 | Q42025 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|---|---|
| Reported | € 0,06 | € 0,08 | € 0,09 | € 0,14 | — | — |
| Estimate | € 0,06 | € 0,09 | € 0,09 | € 0,13 | € 0,09 | € 0,12 |
| Verrassing | 0,00% | -11,11% | 0,00% | +12,00% | — | — |
Growth
Rev 5Y: 23,27% · Earnings 1Y: 32,57%
Growth
Rev 5Y: 23,27% · Earnings 1Y: 32,57%| Revenue Growth (1Y) | 20,52% | Revenue Growth (3Y) | 21,53% |
| Earnings Growth (1Y) | 32,57% | Earnings Growth (3Y) | 20,75% |
| Revenue Growth (5Y) | 23,27% | Earnings Growth (5Y) | 13,10% |
Profitability
ROE: 10,93% · Net Margin: 5,53%
Profitability
ROE: 10,93% · Net Margin: 5,53%| Revenue (TTM) | 270,28 M | Net Income (TTM) | 14,93 M |
| ROE | 10,93% | ROA | 7,72% |
| Gross Margin | 57,52% | Operating Margin | 8,49% |
| Net Margin | 5,53% | Free Cash Flow (TTM) | 11,93 M |
| ROIC | 10,61% | FCF Growth (3Y) | -21,00% |
Safety
D/E: 0,15 · Current: 1,13
Safety
D/E: 0,15 · Current: 1,13| Debt / Equity | 0,15 | Current Ratio | 1,13 |
| Interest Coverage | N/A | Asset Turnover | 1,40 |
| Working Capital | 5,79 M | Tangible Book Value | 73,80 M |
Dividends
Yield: N/A · Payout: N/A
Dividends
Yield: N/A · Payout: N/A| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
Valuation
P/E: 24,87 · EV/EBITDA: 7,37
Valuation
P/E: 24,87 · EV/EBITDA: 7,37| P/E Ratio | 24,87 | Forward P/E | 15,34 |
| P/B Ratio | 2,78 | P/S Ratio | 1,37 |
| PEG Ratio | 1,90 | Forward PEG | 0,53 |
| EV/EBITDA | 7,37 | Fwd EV/EBITDA | N/A |
| Forward P/S | 1,02 | Fwd Earnings Yield | 6,52% |
| FCF Yield | 3,21% | ||
| Market Cap | 371,36 M | Enterprise Value | 379,82 M |
Per Share
EPS: 0,37 · FCF/Share: 0,31
Per Share
EPS: 0,37 · FCF/Share: 0,31| EPS (Diluted TTM) | 0,37 | Revenue / Share | 7,00 |
| FCF / Share | 0,31 | OCF / Share | 1,34 |
| EPS CAGR (1Y) | 32,14% | EPS CAGR (5Y) | 13,88% |
| EPS CAGR (10Y) | N/A | ||
Efficiency
FCF Conv: 79,89% · CapEx/Rev: 14,79%
Efficiency
FCF Conv: 79,89% · CapEx/Rev: 14,79%| CapEx / Revenue | 14,79% | FCF Conversion | 79,89% |
| SBC-Adj. FCF | 3,39 M | Growth Momentum | -2,75 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 270,28 M | 224,26 M | 183,01 M | 138,83 M | 117,06 M |
| Net Income | 14,93 M | 11,27 M | 10,24 M | 6,22 M | 9,13 M |
| EPS (Diluted) | 0,37 | 0,28 | 0,25 | 0,16 | 0,22 |
| Gross Profit | 155,46 M | 133,20 M | 112,78 M | 84,68 M | 73,41 M |
| Operating Income | 22,95 M | 17,90 M | 14,33 M | 8,25 M | 11,58 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 3,02 M | 3,07 M | 2,78 M | 2,70 M | 2,11 M |
| SG&A Expenses | 121,37 M | 106,20 M | 87,88 M | 68,16 M | 54,89 M |
| D&A | 28,61 M | 25,37 M | 21,86 M | — | — |
| Interest Expense | — | — | — | — | — |
| Income Tax | 6,39 M | 4,76 M | 4,15 M | 2,77 M | 3,38 M |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 199,15 M | 177,07 M | 154,90 M | 117,04 M | 117,96 M |
| Total Liabilities | 55,63 M | 43,77 M | 41,00 M | 19,95 M | 23,14 M |
| Shareholders' Equity | 141,55 M | 131,39 M | 113,90 M | 97,09 M | 94,82 M |
| Total Debt | 11,29 M | 3,59 M | 6,00 M | 0,0 | 4,31 M |
| Cash & Equivalents | 13,50 M | 17,54 M | 12,84 M | 16,91 M | 28,41 M |
| Current Assets | 48,49 M | 52,88 M | 38,37 M | 39,74 M | 47,31 M |
| Current Liabilities | 41,06 M | 37,33 M | 32,12 M | 18,86 M | 17,81 M |
Sectorvergelijking
vs Services sector mediaan (615 peers)
Vergeleken met vergelijkbare bedrijven in Services
Sectorvergelijking
vs Services sector mediaan (615 peers) Vergeleken met vergelijkbare bedrijven in Services| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 24,9 | -1,2 |
| P/B | 2,8 | 1,4 |
| ROE % | 10,9 | -16,2 |
| Net Margin % | 5,5 | -19,4 |
| Rev Growth 5Y % | 23,3 | 3,8 |
| D/E | 0,2 | 0,4 |
ETFs Holding This Stock
ETFs Holding This Stock
Strategiescores
1 strategy matched
Strategiescores
1 strategy matched
Growth
Full Throttle
#20 of 21
Recente Activiteit
Ingestapt
Full Throttle
Apr 12, 2026
{"event":"ticker_viewed","properties":{"ticker":"VMD","listing_kind":"stock","pathname":"/stocks/vmd","exchange":"NASDAQ","country":"US"}}